No Cover Image

Journal article 623 views 86 downloads

Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach

Jubie Selvaraj, Shyam Sundar P, Logesh Rajan, Divakar Selvaraj, Dhanabal Palanisamy, Krishnan Namboori PK, Suresh Mohankumar Orcid Logo

RSC Advances, Volume: 11, Issue: 22, Pages: 13051 - 13060

Swansea University Author: Suresh Mohankumar Orcid Logo

  • 56828.pdf

    PDF | Version of Record

    © 2021 The Author(s). This article is licensed under a Creative Commons Attribution 3.0 Unported License

    Download (1.1MB)

Check full text

DOI (Published version): 10.1039/d1ra01603b

Published in: RSC Advances
ISSN: 2046-2069
Published: Royal Society of Chemistry (RSC) 2021
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa56828
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2021-05-07T16:26:42Z
last_indexed 2021-05-27T03:23:01Z
id cronfa56828
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2021-05-26T15:42:47.2145109</datestamp><bib-version>v2</bib-version><id>56828</id><entry>2021-05-07</entry><title>Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach</title><swanseaauthors><author><sid>edce0da45e3933d3460963b966f4c84e</sid><ORCID>0000-0001-8862-2979</ORCID><firstname>Suresh</firstname><surname>Mohankumar</surname><name>Suresh Mohankumar</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-05-07</date><deptcode>PHAR</deptcode><abstract/><type>Journal Article</type><journal>RSC Advances</journal><volume>11</volume><journalNumber>22</journalNumber><paginationStart>13051</paginationStart><paginationEnd>13060</paginationEnd><publisher>Royal Society of Chemistry (RSC)</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>2046-2069</issnElectronic><keywords/><publishedDay>7</publishedDay><publishedMonth>4</publishedMonth><publishedYear>2021</publishedYear><publishedDate>2021-04-07</publishedDate><doi>10.1039/d1ra01603b</doi><url/><notes/><college>COLLEGE NANME</college><department>Pharmacy</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>PHAR</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-05-26T15:42:47.2145109</lastEdited><Created>2021-05-07T17:19:07.9759854</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Jubie</firstname><surname>Selvaraj</surname><order>1</order></author><author><firstname>Shyam Sundar</firstname><surname>P</surname><order>2</order></author><author><firstname>Logesh</firstname><surname>Rajan</surname><order>3</order></author><author><firstname>Divakar</firstname><surname>Selvaraj</surname><order>4</order></author><author><firstname>Dhanabal</firstname><surname>Palanisamy</surname><order>5</order></author><author><firstname>Krishnan Namboori</firstname><surname>PK</surname><order>6</order></author><author><firstname>Suresh</firstname><surname>Mohankumar</surname><orcid>0000-0001-8862-2979</orcid><order>7</order></author></authors><documents><document><filename>56828__20011__a31cec0af7cf45a8986ce6d9086eb1b2.pdf</filename><originalFilename>56828.pdf</originalFilename><uploaded>2021-05-26T15:39:56.7192603</uploaded><type>Output</type><contentLength>1152393</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>&#xA9; 2021 The Author(s). This article is licensed under a Creative Commons Attribution 3.0 Unported License</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/3.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2021-05-26T15:42:47.2145109 v2 56828 2021-05-07 Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach edce0da45e3933d3460963b966f4c84e 0000-0001-8862-2979 Suresh Mohankumar Suresh Mohankumar true false 2021-05-07 PHAR Journal Article RSC Advances 11 22 13051 13060 Royal Society of Chemistry (RSC) 2046-2069 7 4 2021 2021-04-07 10.1039/d1ra01603b COLLEGE NANME Pharmacy COLLEGE CODE PHAR Swansea University 2021-05-26T15:42:47.2145109 2021-05-07T17:19:07.9759854 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Jubie Selvaraj 1 Shyam Sundar P 2 Logesh Rajan 3 Divakar Selvaraj 4 Dhanabal Palanisamy 5 Krishnan Namboori PK 6 Suresh Mohankumar 0000-0001-8862-2979 7 56828__20011__a31cec0af7cf45a8986ce6d9086eb1b2.pdf 56828.pdf 2021-05-26T15:39:56.7192603 Output 1152393 application/pdf Version of Record true © 2021 The Author(s). This article is licensed under a Creative Commons Attribution 3.0 Unported License true eng http://creativecommons.org/licenses/by/3.0/
title Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach
spellingShingle Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach
Suresh Mohankumar
title_short Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach
title_full Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach
title_fullStr Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach
title_full_unstemmed Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach
title_sort Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach
author_id_str_mv edce0da45e3933d3460963b966f4c84e
author_id_fullname_str_mv edce0da45e3933d3460963b966f4c84e_***_Suresh Mohankumar
author Suresh Mohankumar
author2 Jubie Selvaraj
Shyam Sundar P
Logesh Rajan
Divakar Selvaraj
Dhanabal Palanisamy
Krishnan Namboori PK
Suresh Mohankumar
format Journal article
container_title RSC Advances
container_volume 11
container_issue 22
container_start_page 13051
publishDate 2021
institution Swansea University
issn 2046-2069
doi_str_mv 10.1039/d1ra01603b
publisher Royal Society of Chemistry (RSC)
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2021-04-07T04:12:04Z
_version_ 1763753826648588288
score 11.037297

Similar Items